EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 3.0

Strategies and Recent Advances on Improving Efficient Antitumor of Lenvatinib Based on Nanoparticle Delivery System

Haiqing Wang, Wentao Bo, Xielin Feng, Jinliang Zhang, Ge Li, Yan Chen iD

International Journal of Nanomedicine · 2024

DOI: 10.2147/ijn.s460844 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Nanomedicine, 2024. Verfasst von Haiqing Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatopancreatobiliary Surgery, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital and Institute, Affiliated Cancer H…. Hauptthemen laut MEDLINE: Quinolines, Phenylurea Compounds, Antineoplastic Agents, Nanoparticle Drug Delivery System. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 182 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lenvatinib (LVN) is a potentially effective multiple-targeted receptor tyrosine kinase inhibitor approved for treating hepatocellular carcinoma, metastatic renal cell carcinoma and thyroid cancer. Nonetheless, poor pharmacokinetic properties including poor water solubility and rapid metabolic, complex tumor microenvironment, and drug resistance have impeded its satisfactory therapeutic efficacy. This article comprehensively reviews the uses of nanotechnology in LVN to improve antitumor effects. With the characteristic of high modifiability and loading capacity of the nano-drug delivery system, an active targeting approach, controllable drug release, and biomimetic strategies have been devised to deliver LVN to target tumors in sequence, compensating for the lack of passive targeting. The existing applications and advances of LVN in improving therapeutic efficacy include improving longer-term efficiency, achieving higher efficiency, combination therapy, tracking and diagnosing application and reducing toxicity. Therefore, using multiple strategies combined with photothermal, photodynamic, and immunoregulatory therapies potentially overcomes multi-drug resistance, regulates unfavorable tumor microenvironment, and yields higher synergistic antitumor effects. In brief, the nano-LVN delivery system has brought light to the war against cancer while at the same time improving the antitumor effect. More intelligent and multifunctional nanoparticles should be investigated and further converted into clinical applications in the future.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

QuinolinesPhenylurea CompoundsAntineoplastic AgentsNanoparticle Drug Delivery SystemHumansAnimalsTumor MicroenvironmentNeoplasmsNanoparticles

Stichwörter der Autor:innen

antitumordiagnosislenvatinibnano-drug delivery systemside effects

Substanzen

lenvatinibQuinolinesPhenylurea CompoundsAntineoplastic AgentsNanoparticle Drug Delivery System

Autor:innen und Institutionen

  • Department of Hepatopancreatobiliary Surgery, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital and Institute, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, C…
  • Department of Emergency, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital and Institute, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, People's Repu…
  • Department of Pharmacy, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital and Institute, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, People's Repub…

ORCID-Profile: Yan Chen

Zitieren

APA

Wang, H., Bo, W., Feng, X., Zhang, J., Li, G., & Chen, Y. (2024). Strategies and Recent Advances on Improving Efficient Antitumor of Lenvatinib Based on Nanoparticle Delivery System. International Journal of Nanomedicine. https://doi.org/10.2147/ijn.s460844

Vancouver

Wang H, Bo W, Feng X, Zhang J, Li G, Chen Y. Strategies and Recent Advances on Improving Efficient Antitumor of Lenvatinib Based on Nanoparticle Delivery System. International Journal of Nanomedicine. 2024. doi:10.2147/ijn.s460844

BibTeX
@article{Wang2024,
  author = {Wang, Haiqing and Bo, Wentao and Feng, Xielin and Zhang, Jinliang and Li, Ge and Chen, Yan},
  title = {Strategies and Recent Advances on Improving Efficient Antitumor of Lenvatinib Based on Nanoparticle Delivery System},
  journal = {International Journal of Nanomedicine},
  year = {2024},
  doi = {10.2147/ijn.s460844}
}
Kostenlos starten →